Leukotriene CysLT1 receptor antagonist — blocks LTD4 / LTE4 bronchoconstriction. Adjunctive asthma + allergic rhinitis. FDA black-box (2020) for neuropsychiatric adverse events including suicidality.
Teahann Knowledge Base